Syndax Pharmaceuticals (SNDX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Syndax Pharmaceuticals (SNDX) over the last 11 years, with Q3 2025 value amounting to -$1.5 million.
- Syndax Pharmaceuticals' Other Gross PP&E Adjustments fell 698.18% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 698.18%. This contributed to the annual value of -$2.0 million for FY2024, which is 2104.85% up from last year.
- According to the latest figures from Q3 2025, Syndax Pharmaceuticals' Other Gross PP&E Adjustments is -$1.5 million, which was down 698.18% from -$1.6 million recorded in Q2 2025.
- Syndax Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at -$732000.0 for Q2 2021, and its period low was -$3.3 million during Q3 2023.
- Its 5-year average for Other Gross PP&E Adjustments is -$1.9 million, with a median of -$1.9 million in 2022.
- As far as peak fluctuations go, Syndax Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 118333.33% in 2021, and later surged by 5857.19% in 2024.
- Syndax Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$924000.0 in 2021, then plummeted by 113.42% to -$2.0 million in 2022, then dropped by 27.69% to -$2.5 million in 2023, then grew by 21.05% to -$2.0 million in 2024, then grew by 26.01% to -$1.5 million in 2025.
- Its Other Gross PP&E Adjustments was -$1.5 million in Q3 2025, compared to -$1.6 million in Q2 2025 and -$2.9 million in Q1 2025.